An early analysis found reduced use of services targeted by Medicare’s WISeR pilot, but did not establish whether the care avoided was unnecessary, what happened to patients or whether costs fell.
Medicare’s experiment with technology-assisted prior authorization is showing an early decline in use of targeted medical services. But the first analysis does not answer whether care that disappeared was unnecessary, whether patients were denied treatment or whether the program saved money without harming health.
The six-month analysis, reported in JAMA and covered by MarketWatch, examined Medicare’s Wasteful and Inappropriate Service Reduction (WISeR) model. The model uses technology to support prior-authorization reviews for selected services in six states. Researchers measured service use—not medical necessity, denials, patient outcomes or costs.
That distinction matters. Fewer procedures may mean the review process is filtering out low-value care. But a decline could also reflect delays, administrative hurdles or patients giving up while awaiting approval. The study cannot determine which explanation accounts for the change. And a reduction in services does not, by itself, demonstrate that Medicare spending fell; costs were not measured.
The analysis covers only the first six months of a model scheduled to run through Dec. 31, 2031. It is an early signal, not a verdict on long-term performance. A fuller evaluation would need to track what happens to patients and whether utilization changes persist as clinicians and vendors adapt.
The Centers for Medicare & Medicaid Services says a human clinician with relevant expertise must review every “non-affirmation”—a decision not to approve a request. That requirement is a safeguard against leaving unfavorable decisions entirely to an automated system. It does not answer how quickly reviews happen, how often decisions are appealed or reversed, or whether patients receive needed care on time.
The rollout has also drawn scrutiny from the Electronic Frontier Foundation. In an Oct. 27 account of newly released records, EFF said more than 800 pages included CMS corrective-action requests, vendor responses, applications from 66 companies and WISeR contracts. EFF said the rollout produced delays, denials, operational problems and reports of patient harm. The account summarized here does not establish how frequent those problems were or independently quantify their effects.
The records raise questions about contractor oversight as well as clinical results. CMS corrective-action requests and vendor responses are relevant, but the available account does not detail individual vendors’ performance or quantify consequences for beneficiaries. Public reporting on review times, denials, appeals and reversals would help patients and policymakers assess whether safeguards work in practice.
Medicare has a legitimate interest in curbing wasteful spending. But prior authorization carries costs when patients and clinicians must handle paperwork, wait for decisions or appeal refusals. A sound assessment should weigh any savings against those burdens and the consequences of care delayed or forgone. Transparent, timely and clinically grounded rules can protect public funds without weakening the doctor-patient relationship.
The central question is not simply whether technology reduces the number of billed services. It is whether the process identifies inappropriate care while preserving access to treatment patients need. That requires reporting on approvals and denials, review times, appeals, reversals, patient outcomes and total costs. Without those measures, lower utilization is not enough to show that the program is succeeding.
For now, WISeR’s first six months offer a signal, not a scorecard. The longer trial will be more useful if its evaluation follows the dollars to their consequences: what Medicare spends, what it saves and whether beneficiaries receive appropriate care without avoidable delay.
Susan Carter serves as a Senior Correspondent for Just Right News, where she leads the network’s comprehensive coverage of Health, Medicine, and Public Policy. With a career dedicated to dissecting the complexities of the American healthcare system, Susan brings a principled perspective to the most pressing debates of the day. Her reporting is characterized by a commitment to individual liberty, fiscal responsibility, and a healthy skepticism of government overreach, making her a vital voice for audiences seeking clarity in an increasingly regulated landscape.
Raised in Minneapolis, Minnesota, Susan’s professional outlook is deeply informed by the values of the American heartland. Growing up in the Twin Cities, she witnessed firsthand the importance of community-driven solutions and the resilience of the individual. This Midwestern foundation instilled in her a firm belief that the best answers to public policy challenges often come from local innovation and personal responsibility rather than top-down federal mandates. Her background allows her to translate complex legislative jargon into stories that resonate with families who value common sense and local autonomy.
Now based in Baltimore, Maryland, Susan operates from a unique vantage point at the intersection of medical innovation and urban policy. Living and working in a city renowned for its world-class medical institutions and significant public health challenges, she has a front-row seat to the realities of the modern healthcare landscape. Her proximity to these hubs of research and policy allows her to scrutinize how government intervention affects the quality of care and the freedom of medical professionals. In Baltimore, she sees the tangible results of policy decisions, using the city as a lens through which to examine the broader national health debate and the impact of federal spending on local communities.
As the lead for the acclaimed feature series “The Cost of Care,” Susan dives deep into the economic realities facing patients and providers alike. Her work focuses on the necessity of price transparency, the benefits of market competition, and the preservation of the sacred doctor-patient relationship. She is a staunch advocate for the idea that a well-informed public is the best defense against bureaucratic inefficiency. Through this series, she has exposed the hidden drivers of rising medical expenses, always seeking to empower the individual consumer over the massive institution.
Susan’s reporting on public policy is characterized by a commitment to rigorous inquiry and a focus on constitutional limits. Whether she is analyzing new pharmaceutical regulations, investigating the impact of federal health mandates, or exploring the future of medical technology, her goal remains the same: to provide Just Right News audiences with the facts they need to navigate a complex world. By blending her Midwestern sensibilities with the insights gained from her base in Maryland, Susan Carter has become a trusted authority for those who believe that personal freedom and public health are inextricably linked. Her work continues to challenge the status quo, advocating for a system that respects the taxpayer and prioritizes the patient.